Cargando…

DUX4c Is Up-Regulated in FSHD. It Induces the MYF5 Protein and Human Myoblast Proliferation

Facioscapulohumeral muscular dystrophy (FSHD) is a dominant disease linked to contractions of the D4Z4 repeat array in 4q35. We have previously identified a double homeobox gene (DUX4) within each D4Z4 unit that encodes a transcription factor expressed in FSHD but not control myoblasts. DUX4 and its...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ansseau, Eugénie, Laoudj-Chenivesse, Dalila, Marcowycz, Aline, Tassin, Alexandra, Vanderplanck, Céline, Sauvage, Sébastien, Barro, Marietta, Mahieu, Isabelle, Leroy, Axelle, Leclercq, India, Mainfroid, Véronique, Figlewicz, Denise, Mouly, Vincent, Butler-Browne, Gillian, Belayew, Alexandra, Coppée, Frédérique
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2759506/ https://www.ncbi.nlm.nih.gov/pubmed/19829708 http://dx.doi.org/10.1371/journal.pone.0007482

Ejemplares similares

DUX4 expression in FSHD muscle cells: how could such a rare protein cause a myopathy?
por: Tassin, Alexandra, et al.
Publicado: (2013)

The FSHD Atrophic Myotube Phenotype Is Caused by DUX4 Expression
por: Vanderplanck, Céline, et al.
Publicado: (2011)

Overexpression of the double homeodomain protein DUX4c interferes with myofibrillogenesis and induces clustering of myonuclei
por: Vanderplanck, Céline, et al.
Publicado: (2018)

Antisense Oligonucleotides Used to Target the DUX4 mRNA as Therapeutic Approaches in FaciosScapuloHumeral Muscular Dystrophy (FSHD)
por: Ansseau, Eugénie, et al.
Publicado: (2017)

FSHD Myotubes with Different Phenotypes Exhibit Distinct Proteomes
por: Tassin, Alexandra, et al.
Publicado: (2012)

Homologous Transcription Factors DUX4 and DUX4c Associate with Cytoplasmic Proteins during Muscle Differentiation
por: Ansseau, Eugénie, et al.
Publicado: (2016)

The double homeodomain protein DUX4c is associated with regenerating muscle fibers and RNA-binding proteins
por: Claus, Clothilde, et al.
Publicado: (2023)

Myoblasts from affected and non-affected FSHD muscles exhibit morphological differentiation defects
por: Barro, Marietta, et al.
Publicado: (2010)

Dux4 controls migration of mesenchymal stem cells through the Cxcr4-Sdf1 axis
por: Dmitriev, Petr, et al.
Publicado: (2016)

Therapeutic Strategies Targeting DUX4 in FSHD
por: Le Gall, Laura, et al.
Publicado: (2020)

Induction of a local muscular dystrophy using electroporation in vivo: an easy tool for screening therapeutics
por: Derenne, Aline, et al.
Publicado: (2020)

Functional domains of the FSHD-associated DUX4 protein
por: Mitsuhashi, Hiroaki, et al.
Publicado: (2018)

Culture Conditions Affect Expression of DUX4 in FSHD Myoblasts
por: Pandey, Sachchida Nand, et al.
Publicado: (2015)

DUX4 Role in Normal Physiology and in FSHD Muscular Dystrophy
por: Mocciaro, Emanuele, et al.
Publicado: (2021)

Designed U7 snRNAs inhibit DUX4 expression and improve FSHD-associated outcomes in DUX4 overexpressing cells and FSHD patient myotubes
por: Rashnonejad, Afrooz, et al.
Publicado: (2020)

Systemic antisense therapeutics inhibiting DUX4 expression ameliorates FSHD-like pathology in an FSHD mouse model
por: Lu-Nguyen, Ngoc, et al.
Publicado: (2021)

MATR3 is an endogenous inhibitor of DUX4 in FSHD muscular dystrophy
por: Runfola, Valeria, et al.
Publicado: (2023)

Aberrant Splicing in Transgenes Containing Introns, Exons, and V5 Epitopes: Lessons from Developing an FSHD Mouse Model Expressing a D4Z4 Repeat with Flanking Genomic Sequences
por: Ansseau, Eugénie, et al.
Publicado: (2015)

DUX4 Binding to Retroelements Creates Promoters That Are Active in FSHD Muscle and Testis
por: Young, Janet M., et al.
Publicado: (2013)

DUX4 Expression in FSHD Muscles: Focus on Its mRNA Regulation
por: Sidlauskaite, Eva, et al.
Publicado: (2020)

Gene Editing Targeting the DUX4 Polyadenylation Signal: A Therapy for FSHD?
por: Joubert, Romains, et al.
Publicado: (2020)

DUX4 expressing immortalized FSHD lymphoblastoid cells express genes elevated in FSHD muscle biopsies, correlating with the early stages of inflammation
por: Banerji, Christopher R S, et al.
Publicado: (2020)

Biphasic Myopathic Phenotype of Mouse DUX, an ORF within Conserved FSHD-Related Repeats
por: Bosnakovski, Darko, et al.
Publicado: (2009)

PARP1 Differentially Interacts with Promoter region of DUX4 Gene in FSHD Myoblasts
por: Sharma, Vishakha, et al.
Publicado: (2016)

DNA aptamers against the DUX4 protein reveal novel therapeutic implications for FSHD
por: Klingler, Christian, et al.
Publicado: (2020)

An in silico FSHD muscle fiber for modeling DUX4 dynamics and predicting the impact of therapy
por: Cowley, Matthew V, et al.
Publicado: (2023)

Telomere Position Effect (TPE) Regulates DUX4 in Human Facioscapulohumeral Muscular Dystrophy (FSHD)
por: Stadler, Guido, et al.
Publicado: (2013)

Expression of FSHD-related DUX4-FL alters proteostasis and induces TDP-43 aggregation
por: Homma, Sachiko, et al.
Publicado: (2015)

Muscle pathology from stochastic low level DUX4 expression in an FSHD mouse model
por: Bosnakovski, Darko, et al.
Publicado: (2017)

WDR5 is required for DUX4 expression and its pathological effects in FSHD muscular dystrophy
por: Mocciaro, Emanuele, et al.
Publicado: (2023)

DUX4 Differentially Regulates Transcriptomes of Human Rhabdomyosarcoma and Mouse C2C12 Cells
por: Sharma, Vishakha, et al.
Publicado: (2013)

Nuclear bodies reorganize during myogenesis in vitro and are differentially disrupted by expression of FSHD-associated DUX4
por: Homma, Sachiko, et al.
Publicado: (2016)

Proximity ligation assay to detect DUX4 protein in FSHD1 muscle: a pilot study
por: Beermann, Mary Lou, et al.
Publicado: (2022)

Transgenic Drosophila for Investigating DUX4 and FRG1, Two Genes Associated with Facioscapulohumeral Muscular Dystrophy (FSHD)
por: Jones, Takako I., et al.
Publicado: (2016)

Author Correction: Muscle pathology from stochastic low level DUX4 expression in an FSHD mouse model
por: Bosnakovski, Darko, et al.
Publicado: (2018)

PAX7 target gene repression is a superior FSHD biomarker than DUX4 target gene activation, associating with pathological severity and identifying FSHD at the single-cell level
por: Banerji, Christopher R S, et al.
Publicado: (2019)

Asymmetric Bidirectional Transcription from the FSHD-Causing D4Z4 Array Modulates DUX4 Production
por: Block, Gregory J., et al.
Publicado: (2012)

Targeted epigenetic repression by CRISPR/dSaCas9 suppresses pathogenic DUX4-fl expression in FSHD
por: Himeda, Charis L., et al.
Publicado: (2020)

Persistent Fibroadipogenic Progenitor Expansion Following Transient DUX4 Expression Provokes a Profibrotic State in a Mouse Model for FSHD
por: Bosnakovski, Darko, et al.
Publicado: (2022)

A Systemically Administered Unconjugated Antisense Oligonucleotide Targeting DUX4 Improves Muscular Injury and Motor Function in FSHD Model Mice
por: Kakimoto, Tetsuhiro, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4vr12psrr53tve3f5fa6gbshov